Group One Trading
ARCT icon

Group One Trading’s Arcturus Therapeutics ARCT Stock Holding History

Group One Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,427
Closed -$480K – 8074
2025
Q3 		$819K Buy
+44,427
New +$714K ﹤0.01% 3229
2025
Q2 		– Sell
-4,227
Closed -$50K – 7908
2025
Q1 		$44.8K Buy
+4,227
New +$67.1K ﹤0.01% 5253
2024
Q2 		– Sell
-3,810
Closed -$116K – 6672
2024
Q1 		$129K Buy
+3,810
New +$135K ﹤0.01% 3919
2023
Q4 		– Sell
-57,205
Closed -$1.36M – 7343
2023
Q3 		$1.46M Buy
57,205
+7,711
+16% +$238K ﹤0.01% 1903
2023
Q2 		$1.42M Buy
49,494
+5,289
+12% +$144K ﹤0.01% 2019
2023
Q1 		$1.06M Buy
44,205
+8,084
+22% +$145K ﹤0.01% 2091
2022
Q4 		$613K Buy
36,121
+7,739
+27% +$135K ﹤0.01% 2858
2022
Q3 		$421K Sell
28,382
-3,114
-10% -$52.3K ﹤0.01% 3401
2022
Q2 		$496K Buy
+31,496
New +$618K ﹤0.01% 3433
2022
Q1 		– Sell
-20,059
Closed -$512K – 7982
2021
Q4 		$742K Buy
+20,059
New +$817K ﹤0.01% 3660
2021
Q3 		– Sell
-7,754
Closed -$347K – 8134
2021
Q2 		$262K Sell
7,754
-18,452
-70% -$625K ﹤0.01% 4928
2021
Q1 		$1.08M Buy
26,206
+9,057
+53% +$540K ﹤0.01% 3136
2020
Q4 		$744K Sell
17,149
-3,613
-17% -$245K ﹤0.01% 2911
2020
Q3 		$891K Buy
20,762
+2,464
+13% +$122K ﹤0.01% 2310
2020
Q2 		$855K Sell
18,298
-647
-3% -$22.3K ﹤0.01% 2177
2020
Q1 		$257K Sell
18,945
-12,339
-39% -$158K ﹤0.01% 2550
2019
Q4 		$340K Buy
31,284
+16,544
+112% +$173K ﹤0.01% 2765
2019
Q3 		$151K Buy
14,740
+14,596
+10,136% +$158K ﹤0.01% 3276
2019
Q2 		$1K Sell
144
-3,842
-96% -$28.2K ﹤0.01% 4802
2019
Q1 		$27K Sell
3,986
-100
-2% -$512 ﹤0.01% 3889
2018
Q4 		$19K Hold
4,086
– – ﹤0.01% 4035
2018
Q3 		$36K Buy
4,086
+1,285
+46% +$10.7K ﹤0.01% 4138
2018
Q2 		$24K Buy
2,801
+900
+47% +$5.83K ﹤0.01% 4299
2018
Q1 		$10K Buy
1,901
+1,630
+601% +$11.2K ﹤0.01% 4310
2017
Q4 		$2K Buy
+271
New +$2.44K ﹤0.01% 4680
2017
Q3 		– Sell
-713
Closed -$5.37K – 4785
2017
Q2 		$6K Sell
713
-934
-57% -$7.52K ﹤0.01% 4356
2017
Q1 		$13K Sell
1,647
-5,676
-78% -$52.5K ﹤0.01% 4033
2016
Q4 		$108K Sell
7,323
-8,081
-52% -$121K ﹤0.01% 2798
2016
Q3 		$266K Sell
15,404
-14,043
-48% -$454K ﹤0.01% 2274
2016
Q2 		$926K Buy
29,447
+1,014
+4% +$32K 0.01% 1311
2016
Q1 		$754K Sell
28,433
-5,090
-15% -$172K 0.01% 1387
2015
Q4 		$1.47M Buy
33,523
+30,941
+1,198% +$1.39M 0.02% 1055
2015
Q3 		$109K Sell
2,582
-878
-25% -$46.2K ﹤0.01% 2979
2015
Q2 		$158K Sell
3,460
-1,115
-24% -$51.1K ﹤0.01% 2724
2015
Q1 		$180K Sell
4,575
-1,249
-21% -$54.9K ﹤0.01% 2451
2014
Q4 		$152K Buy
+5,824
New +$185K ﹤0.01% 2521

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's ARCT Position: Q4 2025 in Review

Group One Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 44,427 shares — an estimated $480K sold.

Group One Trading first reported a position in ARCT in Q4 2014 and held it in 36 quarters. The position peaked at $1.47M in Q4 2015. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Group One Trading reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 44,427 Arcturus Therapeutics shares in Q4 2025, an estimated $480K.
  • Group One Trading first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 36 quarters.
  • Group One Trading's Arcturus Therapeutics position peaked at $1.47M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.